Biocon And Juno Partner On Liraglutide In Canada

Cites Potential Addressable Canadian Market Of Around $100m For Diabetes Treatment

 
• By Dave Wallace
  
Canadian flags
Biocon and Juno have agreed an alliance on liraglutide in Canada • Source: Shutterstock

More from Deals

More from Business